Last week, Citrix announced a significant product change, which has drawn some ire, but could drive more customers to Citrix Cloud. Starting with Citrix Virtual Apps and Desktops (CVAD) 2003 Current ...
Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma PURPOSE: Two phase II studies were ...
Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy Although all authors completed the disclosure ...
Please provide your email address to receive an email when new articles are posted on . In this video, Lori Muffly, MD, MS, discussed a presentation from the Society of Hematologic Oncology Annual ...
Nikesh Shah, MD, explains a key trial evaluating the efficacy and toxicity of hyper-CVAD in acute lymphocytic leukemia (ALL). Patients were planned to receive a total of 8 cycles of hyper-CVAD.
HOUSTON-A modified "hyper-CVAD" (cyclophosphamide [Cytoxan, Neosar], vincristine, doxorubicin [Adriamycin], dexamethasone) regimen, which included the addition of rituximab (Rituxan) for CD20-positive ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — The addition of nelarabine to a standard hyper-CVAD regimen demonstrated durable overall response ...
Citrix has released two new offerings to help enterprises provide secure application access for their entire workforce amid an evolving threat landscape. The first is its post-quantum cryptography ...
FERNDALE, Mich. -- A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central ...
Virtual desktop platforms are essential for enhancing remote workflows. These platforms create virtualized desktops and apps that can be securely accessed from any remote location and device. Such ...
Therapeutic options in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma (T-ALL/LL) are limited. 1 We have earlier demonstrated that the hyper-CVAD regimen achieves high rates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results